121 related articles for article (PubMed ID: 15829432)
1. Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats.
Beltowski J; Jamroz-Wiśniewska A; Borkowska E; Wójcicka G
Pharmacol Res; 2005 Jun; 51(6):523-32. PubMed ID: 15829432
[TBL] [Abstract][Full Text] [Related]
2. Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.
Bełtowski J; Wójcicka G; Jamroz A
Atherosclerosis; 2003 Sep; 170(1):21-9. PubMed ID: 12957679
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia.
Beltowski J; Wójcicka G; Jamroz-Wiśniewska A; Borkowska E; Marciniak A
Life Sci; 2005 Aug; 77(15):1855-68. PubMed ID: 15913657
[TBL] [Abstract][Full Text] [Related]
4. The paraoxonase 1 (PON1), platelet-activating factor acetylohydrolase (PAF-AH) and dimethylarginine dimethylaminohydrolase (DDAH) activity in the metformin treated normal and diabetic rats.
Wójcicka G; Jamroz-Wiśniewska A; Czechowska G; Korolczuk A; Marciniak S; Bełtowski J
Eur J Pharmacol; 2016 Oct; 789():187-194. PubMed ID: 27450486
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on plasma paraoxonase 1 activity in the rat.
Bełtowski J; Wójcicka G; Jamroz A
Pol J Pharmacol; 2002; 54(6):661-71. PubMed ID: 12866722
[TBL] [Abstract][Full Text] [Related]
6. Species- and substrate-specific stimulation of human plasma paraoxonase 1 (PON1) activity by high chloride concentration.
Bełtowski J; Wójcicka G; Marciniak A
Acta Biochim Pol; 2002; 49(4):927-36. PubMed ID: 12545199
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant treatment normalizes renal Na+,K+-ATPase activity in leptin-treated rats.
Bełtowski J; Jamroz-Wiśniewska A; Borkowska E; Nazar J; Marciniak A
Pharmacol Rep; 2005; 57(2):219-28. PubMed ID: 15886421
[TBL] [Abstract][Full Text] [Related]
8. Phytotherapy in a rat model of hyperoxaluria: the antioxidant effects of quercetin involve serum paraoxonase 1 activation.
Amengual-Cladera E; Nadal-Casellas A; Gómez-Pérez Y; Gomila I; Prieto RM; Proenza AM; Lladó I
Exp Biol Med (Maywood); 2011 Oct; 236(10):1133-8. PubMed ID: 21893570
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension.
Beltowski J; Wójcicka G; Marciniak A; Jamroz A
Life Sci; 2004 Apr; 74(24):2987-3000. PubMed ID: 15051422
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet activating factor acetylhydrolase activities.
Bełtowski J; Wójcicka G; Jamroz A
J Cardiovasc Pharmacol; 2004 Jan; 43(1):121-7. PubMed ID: 14668577
[TBL] [Abstract][Full Text] [Related]
11. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.
Wójcicka G; Jamroz-Wiśniewska A; Marciniak A; Łowicka E; Bełtowski J
Life Sci; 2010 Jul; 87(3-4):126-32. PubMed ID: 20638992
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
Krzystek-Korpacka M; Patryn E; Hotowy K; Czapińska E; Majda J; Kustrzeba-Wójcicka I; Noczyńska A; Gamian A
Adv Clin Exp Med; 2013; 22(2):229-36. PubMed ID: 23709379
[TBL] [Abstract][Full Text] [Related]
13. Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat.
Bełtowski J; Wójcicka G; Mydlarczyk M; Jamroz A
Pol J Pharmacol; 2002; 54(2):143-50. PubMed ID: 12139111
[TBL] [Abstract][Full Text] [Related]
14. Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients.
Varga Z; Paragh G; Seres I; Kakuk G; Karanyi Z; Karpati I; Matyus J; Csongradi E; Juhasz A; Balla J; Bajnok L
Nephron Clin Pract; 2006; 103(3):c114-20. PubMed ID: 16534235
[TBL] [Abstract][Full Text] [Related]
15. Leptin and paraoxonase activity in cord blood from obese mothers.
Ferretti G; Cester AM; Bacchetti T; Raffaelli F; Vignini A; Orici F; Martino C; Tranquilli A
J Matern Fetal Neonatal Med; 2014 Sep; 27(13):1353-6. PubMed ID: 24147648
[TBL] [Abstract][Full Text] [Related]
16. The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity.
Bełtowski J; Wójcicka G; Mydlarczyk M; Jamroz A
J Physiol Pharmacol; 2002 Sep; 53(3):463-75. PubMed ID: 12369742
[TBL] [Abstract][Full Text] [Related]
17. Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
Rusek M; Pastryk JE; Bełtowski J
Chem Biol Interact; 2016 Nov; 259(Pt B):401-406. PubMed ID: 27387541
[TBL] [Abstract][Full Text] [Related]
18. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
[TBL] [Abstract][Full Text] [Related]
19. Enhanced PON1 activity in the kidneys of cyclophosphamide treated rats may play a protective role as an antioxidant against cyclophosphamide induced oxidative stress.
Abraham P; Sugumar E
Arch Toxicol; 2008 Apr; 82(4):237-8. PubMed ID: 17874068
[TBL] [Abstract][Full Text] [Related]
20. Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats.
Trudel K; Sinnett D; James RW; Delvin E; Amre D; Seidman E; Levy E
J Cell Biochem; 2005 Oct; 96(2):404-11. PubMed ID: 16052486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
